Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -438,160 | -251,576 | -128,081 | -79,000 | -142,110 |
| Depreciation Amortization | 86,301 | 30,952 | 26,178 | 18,650 | 5,477 |
| Income taxes - deferred | 5,872 | 8,829 | N/A | 199 | -199 |
| Accounts receivable | -10,483 | 11,525 | -29,589 | -12,203 | -14,842 |
| Other Working Capital | 36,911 | 20,427 | 14,209 | 13,228 | -8,963 |
| Other Operating Activity | 125,488 | 81,204 | 89,642 | 49,063 | 57,071 |
| Operating Cash Flow | $-194,071 | $-98,639 | $-27,641 | $-10,063 | $-103,566 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -495,571 | -337,798 | 21,809 | 93,381 | 106,257 |
| PPE Investments | -17,843 | -13,757 | -7,097 | -3,101 | -1,776 |
| Net Acquisitions | N/A | N/A | -48,892 | N/A | N/A |
| Purchase Of Investment | -10,000 | -4,000 | 0 | N/A | N/A |
| Purchase Sale Intangibles | -38,134 | -31,682 | -8,433 | -77,163 | N/A |
| Other Investing Activity | -38,134 | -31,682 | -8,433 | -77,163 | 0 |
| Investing Cash Flow | $-561,548 | $-387,237 | $-42,613 | $13,117 | $104,481 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 650,000 | 279,267 | 0 | 40,000 | N/A |
| Debt Repayment | -46,162 | -11,667 | 0 | 0 | N/A |
| Common Stock Issued | 103,574 | 345,609 | 131,571 | 4,650 | 968 |
| Other Financing Activity | -38,697 | 0 | 0 | -432 | 0 |
| Financing Cash Flow | $668,715 | $613,209 | $131,571 | $44,218 | $968 |
| Exchange Rate Effect | 7,688 | -1,303 | -3,611 | 6,199 | -1,584 |
| Beginning Cash Position | 295,528 | 169,498 | 111,792 | 58,321 | 58,022 |
| End Cash Position | 216,312 | 295,528 | 169,498 | 111,792 | 58,321 |
| Net Cash Flow | $-79,216 | $126,030 | $57,706 | $53,471 | $299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -194,071 | -98,639 | -27,641 | -10,063 | -103,566 |
| Capital Expenditure | -17,843 | -13,757 | -7,097 | -3,101 | -1,776 |
| Free Cash Flow | -211,914 | -112,396 | -34,738 | -13,164 | -105,342 |